Evidence map›Paper›PMID 41339820›Full record

ArticleBMC public health2025

HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023.

Guligeina Abudurexiti, Kadeliya Muhetaer, Jing Yang, Qian Zhuo, Tingting Qi, Zikereya Saimi, Yumei Ouyang, Huilin Yu, Paizilaiti Yilamujiang, Nafeisha Adili and 3 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Guligeina Abudurexiti *Gynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Kadeliya Muhetaer *Gynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Jing YangGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Qian ZhuoGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Tingting QiGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Zikereya SaimiSchool of Public Health, Xinjiang Medical University, Urumqi, 830000, China.
Yumei OuyangGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Huilin YuGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Paizilaiti YilamujiangGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Nafeisha AdiliGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Nigeerayi NuermaimaitiGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China.
Guzhalinuer AbuliziGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China. gzlnr@qq.com.
Remila RezhakeGynecological oncology center, Affiliated Cancer Hospital of Xinjiang Medical University, 789 Suzhou East Street, Xinshiqu District, Urumqi, 830000, China. ramila513@126.com.

Funding

the Open Research Grant of Xinjiang Key Laboratory of Oncology XJKLO-2023P006the Science and Technology Innovation Leadership Program of Xinjiang Uygur Autonomous Region 2023TSYCLJ0041
6 · The paper itself

Abstract

backgroundFemale students in tertiary vocational institutions, particularly in regions with limited medical resources, play a crucial role in grassroots healthcare and cervical cancer prevention. Understanding their awareness of human papillomavirus (HPV), willingness to receive the HPV vaccine, and perceived barriers is essential for promoting vaccination equity.

methodsA cross-sectional study was conducted from March to April 2023 among female vocational students in southern Xinjiang, China, using a standardized electronic questionnaire. The collected data included sociodemographic characteristics, HPV-related knowledge, vaccination willingness, and barriers. Descriptive statistics and logistic regression analyses were performed.

resultsAmong 1,157 participants, only 37.0% had heard of HPV, and 28.9% were aware of the HPV vaccine. Univariate analysis revealed that non-medical majors and students from rural areas had significantly lower odds of having adequate knowledge (OR = 0.450, 95% CI: 0.360-0.563, p < 0.001; and OR = 0.458, 95% CI: 0.350-0.600, p < 0.001; respectively). In contrast, higher parental education (junior college/bachelor's degree or above) was associated with 58% greater odds of higher awareness (OR = 1.576, 95% CI: 1.119-2.219, p = 0.009). Additionally, students who had not heard of HPV or the HPV vaccine were significantly less likely to possess sufficient awareness (OR = 0.230, 95% CI: 0.181-0.293, p < 0.001; and OR = 0.194, 95% CI: 0.150-0.250, p < 0.001; respectively). Further, multivariate analysis confirmed that major, residence, prior HPV awareness, and vaccine awareness were independent predictors of knowledge level (all p < 0.001). Specifically, medical students demonstrated greater knowledge regarding HPV typing (41.8% vs. 25.6%) and optimal vaccination timing (16.7% vs. 7.9%) than non-medical students. Regarding vaccination attitudes, only 32.1% of the overall students expressed willingness to receive the HPV vaccine, with higher willingness rates observed among medical students (44.6% vs. 19.7%), urban residents (47.8% vs. 27.9%), and individuals who were aware of HPV (50.5%) or the HPV vaccine (59.3%). Actual uptake of HPV vaccine, however, remained low (1.1%-4.5%). Regression analysis showed that medical students had 2.4 times higher vaccination intent, and urban residents exhibited 1.7 times higher intent, compared to their counterparts. Furthermore, awareness was positively correlated with willingness to vaccinate, whereas an earlier age at sexual debut was linked to reduced vaccination intent (OR = 0.57, 95% CI: 0.37-0.89; p = 0.02). The main barrier to vaccination was the low perceived risk associated with young age (45.4%); medical students reported greater concerns about access and cost, whereas psychological barriers, such as worries about side effects and doubts about safety and efficacy, were common across all groups.

conclusionsHPV awareness and vaccination uptake among female vocational students in southern Xinjiang remain low. Targeted health education initiatives should focus on non-medical students, rural populations, and individuals from lower socioeconomic backgrounds. Enhancing vaccine accessibility and affordability through institutional and governmental efforts is critical to improving vaccination coverage in this population.

Indexed as

Health Knowledge, Attitudes, PracticeIntentionPapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareStudentsVaccinationAdolescentAdultChinaCross-Sectional StudiesFemaleHumansSurveys and QuestionnairesUterine Cervical NeoplasmsYoung AdultPapillomavirus VaccinesAwarenessHPV vaccinationHuman papillomavirus (HPV)Vaccination barriersVaccination willingnessVocational students

Identifiers

PMID41339820
PMCPMC12781641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.